Ryan Specialty Holdings, Inc. (NYSE:RYAN) Stake Lifted by Retirement Systems of Alabama

Retirement Systems of Alabama raised its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 4.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 129,368 shares of the company's stock after buying an additional 5,099 shares during the quarter. Retirement Systems of Alabama's holdings in Ryan Specialty were worth $8,300,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Hollencrest Capital Management purchased a new stake in Ryan Specialty in the 3rd quarter valued at about $25,000. Assetmark Inc. acquired a new position in shares of Ryan Specialty in the 3rd quarter valued at about $34,000. Quarry LP lifted its stake in shares of Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after purchasing an additional 422 shares in the last quarter. GAMMA Investing LLC lifted its stake in shares of Ryan Specialty by 106.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,249 shares of the company's stock valued at $83,000 after purchasing an additional 644 shares in the last quarter. Finally, Signaturefd LLC lifted its stake in shares of Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company's stock valued at $89,000 after purchasing an additional 148 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company's stock.

Insider Buying and Selling at Ryan Specialty

In other news, Director David P. Bolger sold 7,055 shares of the business's stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the sale, the director now directly owns 78,149 shares in the company, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of the business's stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96. Following the completion of the sale, the director now owns 45,409 shares of the company's stock, valued at $2,954,309.54. This trade represents a 39.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 323,506 shares of company stock valued at $21,407,851 in the last three months. Corporate insiders own 11.10% of the company's stock.

Ryan Specialty Stock Up 0.7 %

Shares of RYAN traded up $0.48 during trading on Wednesday, reaching $67.10. The company's stock had a trading volume of 913,790 shares, compared to its average volume of 963,885. The company has a fifty day moving average of $65.85 and a two-hundred day moving average of $67.03. Ryan Specialty Holdings, Inc. has a twelve month low of $43.26 and a twelve month high of $75.97. The company has a market cap of $17.57 billion, a price-to-earnings ratio of 87.14, a P/E/G ratio of 1.19 and a beta of 0.72. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on RYAN. Wells Fargo & Company reduced their price objective on Ryan Specialty from $68.00 to $64.00 and set an "equal weight" rating on the stock in a research note on Tuesday, January 14th. Barclays lifted their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research note on Thursday, November 21st. Morgan Stanley started coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price objective on the stock. Finally, Keefe, Bruyette & Woods reduced their price target on Ryan Specialty from $79.00 to $77.00 and set an "outperform" rating on the stock in a research report on Friday, January 10th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $74.40.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.